OREANDA-NEWS. October 22, 2015. The SGX Healthcare Index generated a 10.3% total return in the year through 16 October, taking the three-year total return to 38.5%. In comparison, the MSCI World Healthcare Index generated a 4.5% year-to-date total return over the same period, which brought the three-year total return to 68.8%.

The objective of the SGX Healthcare Index is to capture a broad representation of Singapore’s listed healthcare segment, and complements healthcare stocks under two classification standards – the Global Industry Classification Standard (GICS®) and the Industry Classification Benchmark (ICB). The 29 components of the SGX Healthcare Index are categorised across sub-industries, including healthcare equipment, healthcare supplies, healthcare distributors, healthcare services, healthcare facilities, pharmaceuticals, office services & supplies, and healthcare REITs. The 29 stocks have a combined market capitalisation of S\\$30.9 billion.

The weightings of the Index components are capped at a maximum 10% at each periodical rebalance, so that it is better diversified across a range of stocks. Currently, the five largest stocks by index weight are IHH Healthcare Berhad, Parkway Life REIT, Raffles Medical Group, First REIT and Haw Par Corporation, and they make up more than 50% of the Index.

As of yesterday’s close, the five best performers in the Index were Riverstone Holdings, Q&M Dental Group (Singapore), Cordlife Group, Vicplas International and UG Healthcare Corporation. The five stocks averaged a year-to-date total return of 66.0%.

The tables below are sorted by index weighting. Note that clicking on a stock name will take you to its relevant page on SGX StockFacts.

Source: SGX StockFacts (data as of 19 October 2015)

Source: SGX StockFacts (data as of 19 October 2015)

Showcasing Healthcare Stocks

Earlier this year, SGX embarked on a new initiative – ConnectFacts – to create further investor awareness of its listed companies. It partners global banks and brokerages to provide companies with opportunities to meet institutional and private investors in the US, Europe, Hong Kong, Tokyo and South East Asia. SGX held a two-day event in October, jointly organised with CIMB, to showcase leading Healthcare companies.